Basic Information
InterMune Focuses on Research and Development of Innovative Therapies for Pulmonology and Orphan Fibrotic Diseases. In the field of pulmonology, InterMune concentrates on treatments for Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal lung disease.
InterMune, Inc.
SanFrancisco,California,United States of America
101~500 people
January 01, 1998
ir@intermune.com